These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 25785660

  • 21. Interventions for focal segmental glomerulosclerosis in adults.
    Hodson EM, Sinha A, Cooper TE.
    Cochrane Database Syst Rev; 2022 Feb 28; 2(2):CD003233. PubMed ID: 35224732
    [Abstract] [Full Text] [Related]

  • 22. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N, Kim S, Craig J, Hodson E.
    Arch Dis Child; 2016 Apr 28; 101(4):404-8. PubMed ID: 26289063
    [Abstract] [Full Text] [Related]

  • 23. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2010 Nov 10; (11):CD003594. PubMed ID: 21069676
    [Abstract] [Full Text] [Related]

  • 24. Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP).
    Hahn D, Hodson EM, Willis NS, Craig JC.
    Cochrane Database Syst Rev; 2015 Aug 07; 2015(8):CD005128. PubMed ID: 26258874
    [Abstract] [Full Text] [Related]

  • 25. Interventions for preventing and treating kidney disease in IgA vasculitis.
    Hahn D, Hodson EM, Craig JC.
    Cochrane Database Syst Rev; 2023 Feb 28; 2(2):CD005128. PubMed ID: 36853224
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Lipid-lowering agents for nephrotic syndrome.
    Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L.
    Cochrane Database Syst Rev; 2013 Dec 10; (12):CD005425. PubMed ID: 24327265
    [Abstract] [Full Text] [Related]

  • 28. Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT.
    Christian MT, Webb NJ, Woolley RL, Afentou N, Mehta S, Frew E, Brettell EA, Khan AR, Milford DV, Bockenhauer D, Saleem MA, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Jones C, McKeever K, Cook W, Ives N.
    Health Technol Assess; 2022 Jan 10; 26(3):1-94. PubMed ID: 35060851
    [Abstract] [Full Text] [Related]

  • 29. Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.
    Williams MJ, Ramson JA, Brownfoot FC.
    Cochrane Database Syst Rev; 2022 Aug 09; 8(8):CD006764. PubMed ID: 35943347
    [Abstract] [Full Text] [Related]

  • 30. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Hodson EM, Habashy D, Craig JC.
    Cochrane Database Syst Rev; 2006 Apr 19; (2):CD003594. PubMed ID: 16625586
    [Abstract] [Full Text] [Related]

  • 31. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
    von Groote TC, Williams G, Au EH, Chen Y, Mathew AT, Hodson EM, Tunnicliffe DJ.
    Cochrane Database Syst Rev; 2021 Nov 15; 11(11):CD004293. PubMed ID: 34778952
    [Abstract] [Full Text] [Related]

  • 32. Chinese herbal medicine Huangqi type formulations for nephrotic syndrome.
    Feng M, Yuan W, Zhang R, Fu P, Wu T.
    Cochrane Database Syst Rev; 2013 Jun 05; 2013(6):CD006335. PubMed ID: 23740567
    [Abstract] [Full Text] [Related]

  • 33. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA, Mehndiratta MM, Rajabally YA.
    Cochrane Database Syst Rev; 2017 Nov 29; 11(11):CD002062. PubMed ID: 29185258
    [Abstract] [Full Text] [Related]

  • 34. Prophylactic drug management for febrile seizures in children.
    Offringa M, Newton R, Nevitt SJ, Vraka K.
    Cochrane Database Syst Rev; 2021 Jun 16; 6(6):CD003031. PubMed ID: 34131913
    [Abstract] [Full Text] [Related]

  • 35. Interventions for idiopathic steroid-resistant nephrotic syndrome in children.
    Habashy D, Hodson E, Craig J.
    Cochrane Database Syst Rev; 2004 Jun 16; (2):CD003594. PubMed ID: 15106208
    [Abstract] [Full Text] [Related]

  • 36. Immunosuppressive agents for treating IgA nephropathy.
    Natale P, Palmer SC, Ruospo M, Saglimbene VM, Craig JC, Vecchio M, Samuels JA, Molony DA, Schena FP, Strippoli GF.
    Cochrane Database Syst Rev; 2020 Mar 12; 3(3):CD003965. PubMed ID: 32162319
    [Abstract] [Full Text] [Related]

  • 37. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Chen Y, Schieppati A, Chen X, Cai G, Zamora J, Giuliano GA, Braun N, Perna A.
    Cochrane Database Syst Rev; 2014 Oct 16; 2014(10):CD004293. PubMed ID: 25318831
    [Abstract] [Full Text] [Related]

  • 38. Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients.
    Hahn D, Cody JD, Hodson EM.
    Cochrane Database Syst Rev; 2014 May 28; 2014(5):CD003895. PubMed ID: 24872328
    [Abstract] [Full Text] [Related]

  • 39. Corticosteroids for septic arthritis in children.
    Delgado-Noguera MF, Forero Delgadillo JM, Franco AA, Vazquez JC, Calvache JA.
    Cochrane Database Syst Rev; 2018 Nov 21; 11(11):CD012125. PubMed ID: 30480764
    [Abstract] [Full Text] [Related]

  • 40. Evidence-based management of steroid-sensitive nephrotic syndrome.
    Hodson EM, Craig JC, Willis NS.
    Pediatr Nephrol; 2005 Nov 21; 20(11):1523-30. PubMed ID: 15968558
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.